A Pharmacodynamic Comparison of Prasugrel (LY640315) Versus Clopidogrel in Subjects With Acute Coronary Syndrome Who Are Receiving Clopidogrel
A Pharmacodynamic Comparison of Prasugrel (LY640315) Versus Clopidogrel in Subjects With Acute Coronary Syndrome Who Are Receiving Clopidogrel
This study will compare the effect of a prasugrel 10-mg maintenance dose with a clopidogrel 75-mg maintenance dose on platelet activity, approximately 1 week after the first dose of study drug, in subjects who have been taking clopidogrel 75 mg daily following a percutaneous coronary intervention (PCI) with placement of a stent, performed to treat acute coronary syndrome (ACS).
Inclusion Criteria:
Exclusion Criteria:
Jacksonville, Florida 32209, United States
Baltimore, Maryland 21215, United States
Worcester, Massachusetts 01655, United States
Ann Arbor, Michigan 48109, United States
Cincinnati, Ohio 45219, United States
Columbus, Ohio 43210, United States
Oklahoma City, Oklahoma 73104, United States
Rapid City, South Dakota 57701, United States